Data Collection and Management of mHealth, Wearables, and Internet of Things in Digital Behavioral Health Interventions With the Awesome Data Acquisition Method (ADAM): Development of a Novel Informatics Architecture.

Fitbit Internet of Things IoT IoT integration Nokia behavioral clinical trial management data analysis data collection device integrated system mHealth mHealth Fitbit management mobile health remote assessment research study management study tracking tracking wearable wearable devices

Journal

JMIR mHealth and uHealth
ISSN: 2291-5222
Titre abrégé: JMIR Mhealth Uhealth
Pays: Canada
ID NLM: 101624439

Informations de publication

Date de publication:
07 Aug 2024
Historique:
received: 17 06 2023
revised: 30 04 2024
accepted: 05 06 2024
medline: 8 8 2024
pubmed: 8 8 2024
entrez: 8 8 2024
Statut: epublish

Résumé

The integration of health and activity data from various wearable devices into research studies presents technical and operational challenges. The Awesome Data Acquisition Method (ADAM) is a versatile, web-based system that was designed for integrating data from various sources and managing a large-scale multiphase research study. As a data collecting system, ADAM allows real-time data collection from wearable devices through the device's application programmable interface and the mobile app's adaptive real-time questionnaires. As a clinical trial management system, ADAM integrates clinical trial management processes and efficiently supports recruitment, screening, randomization, data tracking, data reporting, and data analysis during the entire research study process. We used a behavioral weight-loss intervention study (SMARTER trial) as a test case to evaluate the ADAM system. SMARTER was a randomized controlled trial that screened 1741 participants and enrolled 502 adults. As a result, the ADAM system was efficiently and successfully deployed to organize and manage the SMARTER trial. Moreover, with its versatile integration capability, the ADAM system made the necessary switch to fully remote assessments and tracking that are performed seamlessly and promptly when the COVID-19 pandemic ceased in-person contact. The remote-native features afforded by the ADAM system minimized the effects of the COVID-19 lockdown on the SMARTER trial. The success of SMARTER proved the comprehensiveness and efficiency of the ADAM system. Moreover, ADAM was designed to be generalizable and scalable to fit other studies with minimal editing, redevelopment, and customization. The ADAM system can benefit various behavioral interventions and different populations.

Identifiants

pubmed: 39113371
pii: v12i1e50043
doi: 10.2196/50043
doi:

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

e50043

Informations de copyright

© I Wayan Pulantara, Yuhan Wang, Lora E Burke, Susan M Sereika, Zhadyra Bizhanova, Jacob K Kariuki, Jessica Cheng, Britney Beatrice, India Loar, Maribel Cedillo, Molly B Conroy, Bambang Parmanto. Originally published in JMIR mHealth and uHealth (https://mhealth.jmir.org).

Auteurs

I Wayan Pulantara (IW)

School of Health and Rehabilitation Science, University of Pittsburgh, Pittsburgh, PA, United States.

Yuhan Wang (Y)

School of Health and Rehabilitation Science, University of Pittsburgh, Pittsburgh, PA, United States.

Lora E Burke (LE)

School of Nursing, University of Pittsburgh, Pittsburgh, PA, United States.
School of Public Health, University of Pittsburgh, Pittsburgh, PA, United States.

Susan M Sereika (SM)

School of Nursing, University of Pittsburgh, Pittsburgh, PA, United States.
School of Public Health, University of Pittsburgh, Pittsburgh, PA, United States.

Zhadyra Bizhanova (Z)

School of Public Health, University of Pittsburgh, Pittsburgh, PA, United States.

Jacob K Kariuki (JK)

Nell Hodgson Woodruff School of Nursing, Emory University, Atlanta, GA, United States.

Jessica Cheng (J)

School of Public Health, University of Pittsburgh, Pittsburgh, PA, United States.

Britney Beatrice (B)

School of Nursing, University of Pittsburgh, Pittsburgh, PA, United States.

India Loar (I)

School of Nursing, University of Pittsburgh, Pittsburgh, PA, United States.

Maribel Cedillo (M)

School of Medicine, University of Utah, Salt Lake City, UT, United States.

Molly B Conroy (MB)

School of Medicine, University of Utah, Salt Lake City, UT, United States.

Bambang Parmanto (B)

School of Health and Rehabilitation Science, University of Pittsburgh, Pittsburgh, PA, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH